Sergey V. Orlov

Dr. Sergey V. Orlov

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2003 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
IIIrina A. Ignatovich
Irina A. Ignatovich
EDElla B. Dizhe
Ella B. Dizhe
APAnna V. Pavlotskaya
Anna V. Pavlotskaya
BABoris N. Akifiev
Boris N. Akifiev
SBSergey Burov
Sergey Burov
APAndrej P. Perevozchikov
Andrej P. Perevozchikov
Arginine-rich peptides, penetratins, as part of a number of cellular and viral proteins, can penetrate across plasma membrane directly, without participation of endocytosis. We show that one of penetratins, the basic domain 47-57 of human immunodeficiency virus, type 1, transcription factor Tat (Tat peptide), is able to interact with plasmid DNA electrostatically. These interactions result in formation of polyelectrolytic complexes at various negative/positive charge ratios of plasmid DNA and Tat peptide. Plasmid DNA is capable of binding to Tat peptide up to 1.7-fold excess of the complex positive charge. The DNA-Tat complexes can be used for delivery of plasmid DNA into mammalian cells. Transfection efficacy of cultured cells by DNA-Tat complexes is stimulated by free Tat peptide, most likely because it protects DNA-Tat complexes from disruption by anionic proteoglycans of cellular surface. Our data strongly argue in favor of the endocytosis-dependent mechanism of DNA-Tat complex uptake by mammalian cells similarly to internalization of complexes of plasmid DNA with other polycationic carriers. Moreover, different cell lines use different endocytosis-mediated pathways for DNA-Tat complex internalization. Intravenous injections to mice of DNA-Tat complexes in comparison with injections of naked DNA showed an inhibitory effect of DNA-Tat complex positive charge on expression of transferred gene. A low level of foreign gene expression in the liver of mice injected intravenously with positively charged DNA-Tat complexes is accounted for by inactivation of DNA-Tat complexes in the bloodstream due to their interactions with serum albumin. These data should be taken into account in an attempt to develop versatile gene delivery systems based on penetratin application for human disease therapy.

16 November 2009 in Biochemistry
Verified
Journal Article
Closed access
DMDenis A. Mogilenko
Denis A. Mogilenko
EDElla B. Dizhe
Ella B. Dizhe
VSVladimir S. Shavva
Vladimir S. Shavva
ILIvan A. Lapikov
Ivan A. Lapikov
SOSergey V. Orlov
Sergey V. Orlov
APAndrey P. Perevozchikov
Andrey P. Perevozchikov

1 February 2012 in Journal of Biological Chemistry
Verified
Journal Article
Open access
DMDenis A. Mogilenko
Denis A. Mogilenko
IKIgor V. Kudriavtsev
Igor V. Kudriavtsev
ATAndrey S. Trulioff
Andrey S. Trulioff
VSVladimir S. Shavva
Vladimir S. Shavva
EDElla B. Dizhe
Ella B. Dizhe
SOSergey V. Orlov
Sergey V. Orlov
Complement C3 is a pivotal component of three cascades of complement activation. C3 is expressed in human atherosclerotic lesions and is involved in atherogenesis. However, the mechanism of C3 accumulation in atherosclerotic lesions is not well elucidated. We show that acetylated low density lipoprotein and oxidized low density lipoprotein (oxLDL) increase C3 gene expression and protein secretion by human macrophages. Modified LDL (mLDL)-mediated activation of C3 expression mainly depends on liver X receptor (LXR) and partly on Toll-like receptor 4 (TLR4), whereas C3 secretion is increased due to TLR4 activation by mLDL. LXR agonist TO901317 stimulates C3 gene expression in human monocyte-macrophage cells but not in human hepatoma (HepG2) cells. We find LXR-responsive element inside of the promoter region of the human C3 gene, which binds to LXRβ in macrophages but not in HepG2 cells. We show that C3 expression and secretion is decreased in IL-4-treated (M2) and increased in IFNγ/LPS-stimulated (M1) human macrophages as compared with resting macrophages. LXR agonist TO901317 potentiates LPS-induced C3 gene expression and protein secretion in macrophages, whereas oxLDL differently modulates LPS-mediated regulation of C3 in M1 or M2 macrophages. Treatment of human macrophages with anaphylatoxin C3a results in stimulation of C3 transcription and secretion as well as increased oxLDL accumulation and augmented oxLDL-mediated up-regulation of the C3 gene. These data provide a novel mechanism of C3 gene regulation in macrophages and suggest new aspects of cross-talk between mLDL, C3, C3a, and TLR4 during development of atherosclerotic lesions.

1 January 2013 in Journal of Biological Chemistry
Verified
Journal Article
Open access
DMDenis A. Mogilenko
Denis A. Mogilenko
IKIgor V. Kudriavtsev
Igor V. Kudriavtsev
VSVladimir S. Shavva
Vladimir S. Shavva
EDElla B. Dizhe
Ella B. Dizhe
EVEkaterina G. Vilenskaya
Ekaterina G. Vilenskaya
SOSergey V. Orlov
Sergey V. Orlov
Complement C3 is a pivotal component of three cascades of complement activation. The liver is the main source of C3 in circulation and expression and secretion of C3 by hepatocytes is increased during acute inflammation. However, the mechanism of the regulation of the C3 gene in hepatocytes is not well elucidated. We showed that the C3 gene is the direct target for peroxisome proliferator-activated receptor α (PPARα) in human hepatoma HepG2 cells and mouse liver. Using PPARα siRNA and synthetic PPARα agonist WY-14643 and antagonist MK886 we showed that activation of PPARα results in up-regulation of C3 gene expression and protein secretion by HepG2 cells. The PPAR response element (PPRE), which is able to bind PPARα in vitro and in vivo, was found in the human C3 promoter. PPRE is conserved between human and mouse, and WY-14643 stimulates mouse C3 expression in the liver. TNFα increases C3 gene via NF-κB and, to a lesser extent, MEK1/2 signaling pathways, whereas TNFα-mediated stimulation of C3 protein secretion depends on activation of MEK1/2, p38, and JNK in HepG2 cells. Activation of PPARα abolishes TNFα-mediated up-regulation of C3 gene expression and protein secretion due to interference with NF-κB via PPRE-dependent mechanism in HepG2 cells. TNFα decreases PPARα protein content via NF-κB and MEK1/2 signaling pathways and inhibits PPARα binding with the human C3 promoter in HepG2 cells. These results suggest novel mechanism controlling C3 expression in hepatocytes during acute phase inflammation and demonstrate a crosstalk between PPARα and TNFα in the regulation of complement system.

23 January 2012 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
DMDenis A. Mogilenko
Denis A. Mogilenko
SOSergey V. Orlov
Sergey V. Orlov
ATAndrey S. Trulioff
Andrey S. Trulioff
AIAndrei V. Ivanov
Andrei V. Ivanov
VNVadim K. Nagumanov
Vadim K. Nagumanov
APAndrej P. Perevozchikov
Andrej P. Perevozchikov
Apolipoprotein A‐I (ApoA‐I) is the main functional protein component of human high‐density lipoproteins. ApoA‐I shows various anti‐inflammatory and atheroprotective properties toward macrophages; however, endogenous apoA‐I expression has not been investigated in macrophages. We have shown that endogenous apoA‐I gene is expressed in human macrophages at both mRNA and protein levels. Endogenous ApoA‐I is localized in intracellular vesicles and at the external side of the plasma membrane in association with ATP‐binding cassette transporter A1 (ABCA1) and lipid rafts in macrophages. We have shown that endogenous ApoA‐I stabilizes ABCA1, moreover, down‐regulation of ApoA‐I by siRNA results in an increase of Toll‐like receptor 4 (TLR4) mRNA and membrane surface protein expression, as well as an enhancement of bacterial lipopolysaccharide (LPS)‐induced expression of tumor necrosis factor‐α (TNF‐α), interleukin 1β (IL‐1β), and inducible nitric oxide synthase (NOS2) genes in human macrophages. TNF‐α stimulates ApoA‐I expression and secretion (1.2±0.2 vs. 4.3±0.9 ng/mg total protein) in macrophages. Obtained results suggest that endogenous ApoA‐I has anti‐inflammatory properties, presumably due to ABCA1 stabilization in macrophages; these results elucidate the cell type‐specific mechanism of the TNF‐α‐mediated regulation of apoA‐I gene expression in monocytes and macrophages.—Mogilenko, D. A., Orlov, S. V., Trulioff, A. S., Ivanov, A. V., Nagumanov, V. K., Kudriavtsev, I. V., Shavva, V. S., Tanyanskiy, D. A., Perevozchikov, A. P. Endogenous apolipoprotein A‐I stabilizes ATP‐binding cassette transporter A1 and modulates Toll‐like receptor 4 signaling in human macrophages. FASEB J. 26, 2019‐2030 (2012). www.fasebj.org

1 November 2010 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
DMDenis A. Mogilenko
Denis A. Mogilenko
VSVladimir S. Shavva
Vladimir S. Shavva
EDElla B. Dizhe
Ella B. Dizhe
SOSergey V. Orlov
Sergey V. Orlov
APAndrej P. Perevozchikov
Andrej P. Perevozchikov